Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...

DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee ™ a new, AI-powered ...

Please provide your email address to receive an email when new articles are posted on . The machine-learning model successfully identified all eyes with mild NPDR that progressed within 1 year. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Automated insulin delivery can be controlled by a neural ...

Many U.S. hospitals using predictive models are not evaluating their tools internally for accuracy, and fewer still are evaluating them for potential biases, according to a study published in the most ...

Researchers from the Faculty of Medicine at the Chinese University of Hong Kong (CU Medicine) have utilised anonymised big data from the Hospital Authority Data Collaboration Laboratory to develop a ...